Future Perspectives on the Automation and Biocompatibility of Molecularly Imprinted Polymers for Healthcare Applications
Macromolecules · 11.02.2025 · 58 (3) · 1157-1168
DOI: 10.1021/acs.macromol.4c01621 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecules, online erschienen am 01.02.2025. Verfasst von Saweta Garg und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Manchester, School of Engineering, Engineering A Building, Booth East Street, Manchester, M13 9QS, United Kingdom. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Councils UK, U.S. Department of Agriculture.
Abstract (Originalsprache)
Molecular recognition is of crucial importance in several healthcare applications, such as sensing, drug delivery, and therapeutics. Molecularly imprinted polymers (MIPs) present an interesting alternative to biological receptors (e.g., antibodies, enzymes) for this purpose since synthetic receptors overcome the limited robustness, flexibility, high-cost, and potential for inhibition that comes with natural recognition elements. However, off the shelf MIP products remain limited, which is likely due to the lack of a scalable production approach that can manufacture these materials in high yields and narrow and defined size distributions to have full control over their properties. In this Perspective, we will confer how breakthroughs in the automation of MIP design, manufacturing, and evaluation of performance will accelerate the (commercial) implementation of MIPs in healthcare technology. In addition, we will discuss how prediction of the in vivo behavior of MIPs with animal-free technologies (e.g., 3D tissue models) will be critical to assess their clinical potential.
Autor:innen und Institutionen
- University of Manchester, School of Engineering, Engineering A Building, Booth East Street, Manchester, M13 9QS, United Kingdom.
- Newcastle University, Newcastle upon Tyne, Tyne and Wear, NE1 7RU, United Kingdom.
- MIP Discovery, Colworth Park, Sharnbrook, MK44 1LQ, Bedfordshire, United Kingdom.
- University College London, Centre for 3D Models of Health and Disease, Charles Bell House, London, W1W 7TY, United Kingdom.
- University of Leeds, School of Mechanical Engineering, Woodhouse Lane, Leeds, LS2 9JT, United Kingdom.
- School of Chemical, Materials and Biological Engineering, University of Sheffield, Sir Robert Hadfield Building, Mappin Street, Sheffield, S1 3JD, United Kingdom.
ORCID-Profile: Eirini Velliou, James A Dawson, Nikil Kapur, Nicholas J Warren, Marloes Peeters
Förderung
- Research Councils UK
- U.S. Department of Agriculture
Zitieren
APA
Garg, S., Singla, P., Kaur, S., Canfarotta, F., Velliou, E., Dawson, J. A., Kapur, N., Warren, N. J., Amarnath, S., & Peeters, M. (2025). Future Perspectives on the Automation and Biocompatibility of Molecularly Imprinted Polymers for Healthcare Applications. Macromolecules, 58(3), 1157-1168. https://doi.org/10.1021/acs.macromol.4c01621
Vancouver
Garg S, Singla P, Kaur S, Canfarotta F, Velliou E, Dawson JA, et al. Future Perspectives on the Automation and Biocompatibility of Molecularly Imprinted Polymers for Healthcare Applications. Macromolecules. 2025;58(3):1157-1168. doi:10.1021/acs.macromol.4c01621
BibTeX
@article{Garg2025,
author = {Garg, Saweta and Singla, Pankaj and Kaur, Sarbjeet and Canfarotta, Francesco and Velliou, Eirini and Dawson, James A and Kapur, Nikil and Warren, Nicholas J and Amarnath, Shoba and Peeters, Marloes},
title = {Future Perspectives on the Automation and Biocompatibility of Molecularly Imprinted Polymers for Healthcare Applications},
journal = {Macromolecules},
year = {2025},
volume = {58},
number = {3},
pages = {1157--1168},
doi = {10.1021/acs.macromol.4c01621}
}
EUVIMED